Tricenter Assessment of the Efficacy of the ACE Inhibitor, Moexipril, by Ambulatory Blood Pressure Monitoring

The Journal of Clinical Pharmacology

Volumn 35, Issue 3, 1995, Pages 233-238

  White, William B ^a   Whelton, Andrew ^b   Fox, Alanna A L ^d   Stimpel, Michael ^d   Kaihlanen, Paul M ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c South Texas Medical Research Associates   (United States)

^d Schwarz Pharma AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOEXIPRIL;

AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0028952780     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1995.tb04052.x     Document Type: Article

References (18)

1. Usefulness of ambulatory monitoring of the blood pressure to assess antihypertensive therapy
2. Assessment of the average daily blood pressure load as a determinant of cardiac function in patients with mild to moderate hypertension
3. Ambulatory blood pressure monitoring
4. Once‐daily lisinopril compared with twice‐daily captopril in the treatment of mild to moderate hypertension: Assessment of office and ambulatory blood pressures
5. Methods of blood pressure determination to assess antihypertensive agents: Are casual measurements enough
6. Can an angiotensin‐converting enzyme inhibitor with a short half‐life effectively lower blood pressure for 24 hours
7. In vitro and in vivo characterization of the new ACE inhibitor moexipril: Comparison with enalapril
8. Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: Assessment of performance in two countries and comparison with sphygmomanometry and intraarterial blood pressure at rest and during exercise
9. Reproducibility of noninvasive and intraarterial blood pressure monitoring: Implications for studies on antihypertensive treatment
10. Ambulatory blood pressure monitoring in the evaluation of drug efficacy
11. Value of ambulatory blood pressure monitoring in clinical pharmacology
12. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring: Implications for studies on antihypertensive drugs
13. Long‐term efficacy and safety of moexipril, alone and in combination with hydrochlorothiazide, in patients with hypertension
14. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents
15. Ambulatory blood pressure and target organ involvement in hypertension
16. The prognostic value of ambulatory blood pressures
17. The role of ambulatory monitoring of the blood pressure for assessment of antihypertensive agents